New Oral Weight-Loss Pill Foundayo Approved for UK — First in Europe
The MHRA has approved Foundayo (orforglipron), a daily GLP-1 weight-loss pill made by Eli Lilly, for treating obesity and type 2 diabetes. The UK is the first European country to approve it. The pill is expected to be cheaper than existing injections, more convenient (can be taken any time of day, unlike the Wegovy pill), and trials suggest it can help patients maintain weight loss after coming off jabs. NHS availability is not automatic and requires a separate NICE recommendation.
Source: BBC News
Why it matters: Expanding weight-loss treatment options with NHS access implications — a practical health story.
while I don’t think I will ever need to take any pills and am not far from a good level of body fat percentage and weight I am interested in how we address weight issues including education